Leadership
;
About
Collaboration is a key value at the heart of OICR.
Collaboration is an integral driver of our leadership team, which brings together experts with diverse voices, backgrounds and skill sets to lead our shared pursuit of world-class translational cancer research together. OICR is overseen by a volunteer Board of Directors, which is responsible for the success and sustainability of the Institute and the overall governance of the affairs of the corporation.
OICR has joined the 50 – 30 Challenge. This is a challenge to increase the representation and inclusion of diverse groups within the workplace
Executive
Laszlo Radvanyi, PhD
President and Scientific Director
Christine Williams, PhD
Executive Vice President and Head of Implementation Science
Lincoln Stein, MD, PhD
Head, Adaptive Oncology
Rima Al-awar, PhD
Head, Therapeutic Innovation and Drug Discovery
Steven Gallinger, MD, MSc, FRCSC
Head, Clinical Translation and Co-Lead, PanCuRx
Rebecca Tamarchak, PhD
Head of Strategy, Governance and Partnerships
Jeanette Dias D’Souza, CPA, CA, ICD.D
Senior Vice President, Corporate Services and Group Chief Financial Officer of OICR and FACIT
Board of Directors
Susan Fitzpatrick (Chair)
Head Canadian Drug Agency Transition Office at Health Canada
Jason Berman, MD
Chief Executive Officer and Scientific Director, Children’s Hospital of Eastern Ontario (CHEO); Research Institute and Vice President Research, CHEO
Rodney Cheung, P. Eng, EMBA
Global Chief Information Officer (CIO), BGIS
Jennifer Chan, MD
Director of the Arnie Charbonneau Cancer Institute and an Associate Professor in the Department of Pathology & Laboratory Medicine, at the University of Calgary
Janice Deakin, PhD
President and CEO, Higher Education Quality Council
Laurie Harrison
Former Vice President, Finance and Chief Financial Officer, Hospital for Sick Children
Wendy Kelley, JD
Ken Lawless, MSc
President and Chief Executive Officer, Epitope Capital Corp.
Anne-Marie Mes-Masson, PhD
Professor at the Faculty of Medicine of the University of Montreal, Deputy Scientific Director, Basic and Translational Research at the Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM).
Ken Newport, CPA
Chair, BioCanRx
Nancy Ross, PhD
Vice-Principal Research, Queen’s University
Dawn Powell, MSc
President, Dawn M. Powell Appraisals
Bradly G. Wouters, PhD
Executive Vice President, Science and Research, University Health Network
Scientific Advisory Board
Richard L. Schilsky, MD, FASCO (Chair)
- Former Senior Vice President and Chief Medical Officer, American Society of Clinical Oncology
Ewan Birney, PhD
- Director and Joint Head of Research and Senior Scientist, European Bioinformatics Institute (EMBL-EBI)
Hakim Djaballah, PhD
- President and CEO, Keren Therapeutics
Olivera J. Finn, PhD
- Chair and Professor, Department of Immunology
University of Pittsburgh School of Medicine - Director, Immunology Program
University of Pittsburgh Cancer Institute
Funda Meric-Bernstam, MD
- Department of Investigational Cancer Therapeutics,
Division of Cancer Medicine
MD Anderson Cancer Center
Edward F. Patz, MD
- James and Alice Chen Distinguished Professor of Radiology
Professor of Radiology
Professor in Pathology
Professor in Pharmacology & Cancer Biology
Member of the Duke Cancer Institute
Sylvia K. Plevritis, PhD
- Professor and Chair
Department of Biomedical Data Science
Deborah Schrag, MD, MPH
- Chair of the Department of Medicine
Memorial Sloan Kettering Cancer Center
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.